Radiosurgery and hypofractionated reirradiation in progression of hemispheric glioblastomas
Authors:
- Александра БеляшоваАБАлександра Беляшова
- Иван Константинович ОсиновИОИван Константинович Осинов
- Григорий Львович КобяковГКГригорий Львович Кобяков
- Юрий Юрьевич ТрунинЮТЮрий Юрьевич Трунин
- Светлана Вячеславовна ЗолотоваСЗСветлана Вячеславовна Золотова
- Наталья Анатольевна АнтипинаНАНаталья Анатольевна Антипина
- Валерий Валерьевич КостюченкоВКВалерий Валерьевич Костюченко
- Андрей Владимирович ГолановАГАндрей Владимирович Голанов
- Оксана Владиславовна АбсалямоваОАОксана Владиславовна Абсалямова
- Галина Валерьевна ПавловаГПГалина Валерьевна Павлова
Open Access
- 30 June 2023
- journal article
- research article
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 69 (3) , 452-461
Abstract
Introduction. Glioblastomas (WHO grade IV) are the most common primary malignant tumors of the CNS with an extremely poor prognosis. Despite combined treatment, which includes maximal surgical removal followed by radiation and chemotherapy, the vast majority of cases experience progression within several months after surgery. Repeated radiation therapy is one of the most common and effective therapeutic options when progression is detected. Aim. To study the efficacy and safety of stereotactic radiation therapy in treating glioblastoma progression in radiosurgery and hypofractionation modes. Materials and methods. The study included 163 patients with glioblastoma (GB) progression after complex treatment from 2005 to 2021. All patients were treated in the radiotherapy department of the National Medical Research Center for Neurosurgery and the Moscow Gamma Knife Center. The age of patients included in the study ranged from 18 to 73.9 years. The median age was 49.5 years (95 % CI 47-52.3). In the mode of radiosurgery (for one fraction), 180 foci were treated (located "locally" within 3 cm from the prescribed isodose at primary irradiation — 122, and 58 — distant). In the hypofractionation mode, 107 foci were treated (local — 67 and distant — 40). The mean volumes of foci were 9.2 cm3 (0.01-43.2 cm3) in the radiosurgery mode and 17.84 cm3 (0.1-72 cm3) in the hypofractionation mode. The median prescribed dose in the radiosurgery mode was 20 Gy at 50 % of the isodose curve. The median cumulative focal dose in the hypofractionation mode was 30 Gy. Results. Analysis of the treatment results in radiosurgery mode showed that for local progression, local control at 3, 6, and 12 months was 98.1 %, 76.3 %, and 38.5 %, respectively, while for distant progression it was 100 %, 80.1 %, and 67.2 %, respectively. In hypofractionation mode, the local control of foci of local progression at 3, 6, and 12 months was 90.2 %, 73.2 %, and 23.6 %, respectively, and for distant progression it was 97.6 %, 86.2 %, and 59.4 %, respectively. Grade 3 radiation toxicity after radiosurgery was observed in 8.8 % of patients. Grade 3-4 radiation toxicity after hypofractionation in the form of edema was observed in 18.2 % of patients, and post-radiation necrosis was observed in 13.4 % of patients. In the hypofractionation mode, the mean volume of the focus in the group with post-radiation toxicity was 22.7 cm3, while in the group without post-radiation toxicity it was 15.2 cm3. Conclusion: Stereotactic radiotherapy for glioblastoma progression in radiosurgery and hypofractionation modes is an effective and safe treatment option that leads to an increase in the duration of local tumor control. Repeating radiotherapy for distant glioblastoma progression significantly increases local control compared to local progression. Глиобластомы (WHO grade IV) – самые распространённые первичные злокачественные опухоли ЦНС с крайне неблагоприятным прогнозом. Несмотря на проводимое комбинированное лечение, включающее в себя максимально возможное удаление с последующей лучевой и химиотерапией, в абсолютном большинстве случаев прогрессирование глиобластом происходит в течение нескольких месяцев после операции. Проведение повторной лучевой терапии является одной из распространенных и эффективных терапевтических опций при выявлении прогрессии. Цель исследования: Изучить эффективность и безопасность стереотаксической лучевой терапии в лечении прогрессий глиобластом в режимах радиохирургии и гипофракционирования. Материал и методы: В исследование за период с 2005 по 2021 включено 163 пациента с прогрессированием глиобластомы (ГБ) после комплексного лечения. Все пациенты были пролечены в отделении радиотерапии НМИЦ нейрохирургии и Московском центре Гамма Нож. Возраст пациентов, включенных в исследование, составил от 18 до 73,9 лет. Медиана возраста составила 49,5 лет (95% ДИ 47 - 52,3). В режиме радиохирургии (за одну фракцию) было пролечено 180 очагов (расположенных «локально» - в пределах 3 см от предписаной изодозы при первичном облучении 123 и 58 - дистантных); в режиме гипофракционирования было пролечено 107 очагов (локальных 67 и дистантных 40). Средние объемы очагов: в режиме радиохирургии – 9,2 см3 (0,01-43,2 см3) при гипофракционировании – 17,84 см3 (0,1-72 см3). Медиана предписанной дозы в режиме радиохирургии – 20Гр по 50% изодозной кривой. Медиана суммарной очаговой дозы в режиме гипофракционирования – 30Гр. Результаты: При анализе результатов лечения в режиме радиохирургии выявлено, что при локальном типе прогрессии локальный контроль на сроке 3,6,12...Keywords
This publication has 22 references indexed in Scilit:
- Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boostJournal of Cancer Research and Clinical Oncology, 2021
- A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital BiomarkersCurrent Treatment Options in Oncology, 2019
- Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysisWorld Neurosurgery, 2019
- Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastomaJournal of Neuro-Oncology, 2019
- Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysisJournal of Neuro-Oncology, 2018
- Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questionsCritical Reviews in Oncology/Hematology, 2018
- A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With GlioblastomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Gamma Knife Surgery versus Reoperation for Recurrent Glioblastoma MultiformeWorld Neurosurgery, 2012
- Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant GliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999